Role of disease-modifying drugs in osteoarthritis and pharmaconutraceuticals in the treatment of chronic non-specific back pain

In September 2025, an expert council meeting was held to discuss the role and importance of disease-modifying drugs for osteoarthritis and pharmaconutraceuticals in the treatment of chronic nonspecific back pain. This meeting presented data from studies examining efficacy and safety of bioactive extract and concentrate from small sea fish, chondroitin sulfate, glucosamine and their combinations, as well as some pharmaconutraceuticals in the treatment of musculoskeletal back pain. There is a need to include these agents in clinical guidelines for the management of chronic musculoskeletal back pain for its effective and safe management and prevention.

Authors

Institutions

Publication Details

Journal
Russian Journal of Pain
Published
2026-07-01
DOI
https://doi.org/10.17116/pain202624021106
Primary Topic
Seaweed-derived Bioactive Compounds
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Role of disease-modifying drugs in osteoarthritis and pharmaconutraceuticals in the treatment of chronic non-specific back pain

А. М. Лила, С. А. Живолупов, Maxim V. Churyukanov, И. В. Сарвилина et al.
Russian Journal of Pain
Seaweed-derived Bioactive Compounds
article

Role of disease-modifying drugs in osteoarthritis and pharmaconutraceuticals in the treatment of chronic non-specific back pain

А. М. Лила, С. А. Живолупов, Maxim V. Churyukanov, И. В. Сарвилина, Д. С. Зубков, О.С. Давыдов, А. В. Наумов, Е. Р. Баранцевич, Mikhail Lvovich Kukushkin, Е. А. Таскина, M.A. Bakhtadze, V.A. Shirokov, Ф. А. Хабиров
article en

Abstract

In September 2025, an expert council meeting was held to discuss the role and importance of disease-modifying drugs for osteoarthritis and pharmaconutraceuticals in the treatment of chronic nonspecific back pain. This meeting presented data from studies examining efficacy and safety of bioactive extract and concentrate from small sea fish, chondroitin sulfate, glucosamine and their combinations, as well as some pharmaconutraceuticals in the treatment of musculoskeletal back pain. There is a need to include these agents in clinical guidelines for the management of chronic musculoskeletal back pain for its effective and safe management and prevention.

Russian Journal of PainVol. 24(2)
Sechenov University (RU), First Pavlov State Medical University of St. Petersburg (RU), S. M. Kirov Military Medical Academy (RU), Pirogov Russian National Research Medical University (RU), Novomer (United States) (US), Institut für Hygiene und Umwelt (DE), Association of Rheumatologists of Russia (RU), Kazan State Medical Academy (RU), Research Institute of General Pathology and Pathophysiology, the Russian Academy of Medical Sciences (RU), Regional Clinical Research (US), Russian Scientific Center of Surgery (RU)
Life below water
Openalex Percentile: Top 6%
Seaweed-derived Bioactive Compounds
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.